Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City

American Journal of Public Health

Volumn 103, Issue 9, 2013, Pages 1579-1582

  Crawford, Natalie D ^a   Amesty, Silvia ^b   Rivera, Alexis V ^c   Harripersaud, Katherine ^c   Turner, Alezandria ^c   Fuller, Crystal M ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PHARMACY; PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; STATISTICS; SUBSTANCE ABUSE; SYRINGE; UNITED STATES;

AIDS SERODIAGNOSIS; HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; PHARMACIES; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 84881502387     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.301178     Document Type: Article

References (22)

1. Friedman SR, Neaigus A, Des Jarlais DC, et al. Social intervention against AIDS among injecting drug users. Br J Addict. 1992;87(3):393-404.
2. Blankenship KM, Friedman SR, Dworkin S, Mantell JE. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83 (1):59-72.
3. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(suppl 1): S11-S21.
4. Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis. 2005;191(suppl 1): S7-S24.
5. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97(1):117-124.
6. HIV/AIDS Surveillance Report, 2007. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
7. Deren S, Cleland CM, Fuller C, Kang SY, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav. 2006;10(6):717-721.
8. Cleland CM, Deren S, Fuller CM, et al. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007;34(2):390-403.
9. Jones TS, Coffin PO. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc (Wash). 2002;42 (6 suppl 2):S6-S9.
10. Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005;39(4):471-477.
11. Fuller CM, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis. 2004;14(4):589-596.
12. New York City HIV/AIDS Annual Surveillance Statistics. New York: New York City Department of Health and Mental Hygiene; 2010.
13. Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ ethnic composition and need. J Urban Health. 2009;86 (6):929-945.
14. Cooper HL, Des Jarlais DC, Ross Z, Tempalski B, Bossak B, Friedman SR. Spatial access to syringe exchange programs and pharmacies selling over-thecounter syringes as predictors of drug injectors' use of sterile syringes. Am J Public Health. 2011;101(6): 1118-1125.
15. Rivera AV, Blaney S, Crawford ND, et al. Individualand neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program. J Am Pharm Assoc (2003). 2010;50(5):580-587.
16. Facilities EL, ed. SAS 9.2. Cary, NC: SAS Institute Inc; 2008.
17. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002;42(6 suppl 2):S77-S82.
18. Vlahov D, Fuller C, Finkelstein R, et al. New York State Expanded Syringe Access Demonstration Program: Evaluation Report to the Governor and the New York State Legislature. New York, NY: New York Academy of Medicine; 2003.
19. Crawford ND, Blaney S, Amesty S, et al. Individualand neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAPregistered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health. 2011;88(1):176-185.
20. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA. 2000;284(16):2061-2069.
21. Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004;19(4):349-356.
22. Branson B. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. J Med Virol. 2007;79(suppl 1):S6-S10.